Quotient (QTNT) Downgraded to “Sell” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research lowered shares of Quotient (NASDAQ:QTNT) from a hold rating to a sell rating in a research note published on Friday.

According to Zacks, “Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania. “

A number of other analysts have also issued reports on the company. ValuEngine upgraded Quotient from a hold rating to a buy rating in a research note on Thursday, October 18th. BidaskClub upgraded Quotient from a sell rating to a hold rating in a research report on Tuesday, October 2nd.

Shares of NASDAQ:QTNT traded down $0.17 during midday trading on Friday, reaching $6.50. 78,881 shares of the company traded hands, compared to its average volume of 220,366. Quotient has a 12 month low of $2.78 and a 12 month high of $9.02. The firm has a market cap of $367.28 million, a price-to-earnings ratio of -3.22 and a beta of 0.45.

Quotient (NASDAQ:QTNT) last released its quarterly earnings data on Monday, November 5th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.17). The company had revenue of $6.25 million during the quarter, compared to the consensus estimate of $5.80 million. On average, sell-side analysts predict that Quotient will post -1.92 EPS for the current fiscal year.

A number of institutional investors have recently bought and sold shares of QTNT. Millennium Management LLC purchased a new position in Quotient during the second quarter worth about $3,699,000. Point72 Asset Management L.P. purchased a new position in Quotient during the second quarter worth about $3,179,000. Quantum Capital Management grew its position in Quotient by 407.7% during the third quarter. Quantum Capital Management now owns 270,961 shares of the company’s stock worth $2,046,000 after buying an additional 217,593 shares in the last quarter. Gilder Gagnon Howe & Co. LLC purchased a new position in Quotient during the second quarter worth about $1,702,000. Finally, Bellevue Group AG grew its position in Quotient by 190.7% during the second quarter. Bellevue Group AG now owns 319,814 shares of the company’s stock worth $2,568,000 after buying an additional 209,814 shares in the last quarter. Institutional investors and hedge funds own 49.19% of the company’s stock.

About Quotient

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.

See Also: Float

Get a free copy of the Zacks research report on Quotient (QTNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.